Scientific Opinion on the substantiation of health claims related to walnuts and maintenance of normal blood LDL-cholesterol concentrations (ID 1156, 1158) and improvement of endothelium-dependent vasodilation (ID 1155, 1157) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
Published:
Adopted:
Share:
Meta data
EFSA Journal 2011;9(4):2074
Keywords
Walnuts, fatty acids, cholesterol, vasodilation, health claims
On request from
European Commission
Question Number
EFSA-Q-2008-1894
EFSA-Q-2008-1895
EFSA-Q-2008-1896
EFSA-Q-2008-1897
Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen.
Contact
nda [at] efsa.europa.eu
Abstract
No abstract available
© European Food Safety Authority, 2011